Aarti Pharmalabs Ltd.

The June 2024 quarter revenue stood at Rs. 3934.86 millions, up 9.87% as compared to Rs. 3581.44 millions during the corresponding quarter last year.The Company's Net profit for the June 2024 quarter have declined marginally to Rs. 471.44  millions as against Rs. 476.32 millions reported during the corresponding quarter ended.Operating Profit saw a handsome growth to 857.68 millions from 816.03 millions in the quarter ended June 2024.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202406	202306	% Var	202406	202306	% Var	202403	202303	% Var
Sales	3934.86	3581.44	9.87	3934.86	3581.44	9.87	15021.30	15112.50	-0.60
Other Income	21.13	48.59	-56.51	21.13	48.59	-56.51	110.10	12.80	760.16
PBIDT	857.68	816.03	5.10	857.68	816.03	5.10	3571.60	3096.20	15.35
Interest	42.49	40.34	5.33	42.49	40.34	5.33	166.30	204.90	-18.84
PBDT	815.19	775.69	5.09	815.19	775.69	5.09	3405.30	2891.30	17.78
Depreciation	182.93	154.37	18.50	182.93	154.37	18.50	660.10	557.70	18.36
PBT	632.26	621.32	1.76	632.26	621.32	1.76	2745.20	2333.60	17.64
TAX	160.82	145.00	10.91	160.82	145.00	10.91	738.70	616.30	19.86
Deferred Tax	45.15	35.00	29.00	45.15	35.00	29.00	278.10	95.00	192.74
PAT	471.44	476.32	-1.02	471.44	476.32	-1.02	2006.50	1717.30	16.84
Equity	453.13	453.13	0.00	453.13	453.13	0.00	453.10	453.10	0.00
PBIDTM(%)	21.80	22.78	-4.34	21.80	22.78	-4.34	23.78	20.49	16.05